EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 63 filers reported holding EVELO BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,643 | -90.8% | 25,695 | -18.0% | 0.00% | – |
| Q4 2022 | $50,451 | -28.9% | 31,336 | -8.0% | 0.00% | – |
| Q3 2022 | $71,000 | -20.2% | 34,065 | -19.0% | 0.00% | – |
| Q2 2022 | $89,000 | -51.4% | 42,039 | -22.1% | 0.00% | – |
| Q1 2022 | $183,000 | -39.4% | 53,959 | +8.2% | 0.00% | – |
| Q4 2021 | $302,000 | +11.4% | 49,857 | +29.5% | 0.00% | – |
| Q3 2021 | $271,000 | -26.4% | 38,492 | +43.7% | 0.00% | – |
| Q2 2021 | $368,000 | +145.3% | 26,779 | +90.4% | 0.00% | – |
| Q1 2021 | $150,000 | +10.3% | 14,063 | +25.3% | 0.00% | – |
| Q4 2020 | $136,000 | +151.9% | 11,219 | +10.1% | 0.00% | – |
| Q3 2020 | $54,000 | -97.8% | 10,194 | -96.2% | 0.00% | -100.0% |
| Q2 2019 | $2,421,000 | +12.1% | 269,645 | -0.1% | 0.00% | 0.0% |
| Q1 2019 | $2,159,000 | -41.9% | 269,819 | -5.5% | 0.00% | 0.0% |
| Q4 2018 | $3,715,000 | -2.9% | 285,543 | -9.1% | 0.00% | 0.0% |
| Q3 2018 | $3,824,000 | -3.8% | 313,963 | -6.8% | 0.00% | 0.0% |
| Q2 2018 | $3,974,000 | – | 336,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 50,427,328 | $105,393,000 | 4.44% |
| HARBOURVEST PARTNERS LLC | 3,063,505 | $6,403,000 | 2.09% |
| CVI Holdings, LLC | 1,693,655 | $3,540,000 | 0.27% |
| Alphabet Inc. | 1,060,495 | $2,216,000 | 0.11% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 4,070,728 | $8,508,000 | 0.06% |
| CREDIT SUISSE AG/ | 3,670,178 | $7,670,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 105,300 | $220,000 | 0.01% |
| FMR LLC | 16,199,055 | $33,856,000 | 0.00% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 25,346 | $53,000 | 0.00% |
| Ergoteles LLC | 27,429 | $57,000 | 0.00% |